Sodium 4-Carboxymethoxyimino-(4-HPR) a Novel Water-Soluble Derivative of 4-Oxo-4-HPR Endowed with In Vivo Anticancer Activity on Solid Tumors
4-oxo-N-(4-hydroxyphenyl)retinamide (4-oxo-4-HPR), an active polar metabolite of the synthetic retinoid N-(4-hydroxyphenyl)retinamide (4-HPR), was shown to exert promising antitumor activity through at least two independent mechanisms of action. Specifically, differently from 4-HPR and other retinoi...
Main Authors: | Valentina Appierto, Paola Tiberio, Elena Cavadini, Loredana Cleris, Sabrina Dallavalle, Loana Musso, Maria G. Daidone |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00226/full |
Similar Items
-
Design and Implementation of Core Surveillance System for HPR1000 Reactor
by: ZHANG Xiangju, CAI li, WANG Junling, YANG Mengyi, LUO Shijie, LU Haoliang, PENG Sitao, LI Jinggang, WANG Ting
Published: (2024-07-01) -
AF1q: a novel mediator of basal and 4-HPR-induced apoptosis in ovarian cancer cells.
by: Paola Tiberio, et al.
Published: (2012-01-01) -
Retinoids Delivery Systems in Cancer: Liposomal Fenretinide for Neuroectodermal-Derived Tumors
by: Veronica Bensa, et al.
Published: (2021-08-01) -
HPR1000: Advanced Pressurized Water Reactor with Active and Passive Safety
by: Ji Xing, et al.
Published: (2016-03-01) -
Research on Equipment Qualification for Pressure Transmitter Important to Safety of HPR1000
by: Peng GAO
Published: (2022-06-01)